Bio Pharma Dive

APRIL 22, 2024

A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of the complex cellular treatments.

Production 293

Production Manufacturing 293

Pharmaceutical Technology

FEBRUARY 21, 2024

Contract development and manufacturing organisation Genezen has announced plans to license CSL’s Cytegrity lentivirus production system.

Licensing 130

Licensing Licensing Production Manufacturing 130

Bio Pharma Dive

MAY 15, 2023

Vetter brings a proven launch management process that combines extensive experience with in-depth product knowledge.

Production 256

Production Drugs 256

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

Pharmaceutical Technology

APRIL 13, 2023

The now expanded agreement will enable Rubic to explore other therapeutic avenues in both the human and animal health product markets. The extension of the agreement beyond its original Covid-19 focus will accelerate development timelines, increase productivity, and lower manufacturing costs, according to Dyadic’s CEO Mark Emalfarb.

Production 279

Production Vaccination Vaccine Protein 279

Fierce Pharma

APRIL 18, 2024

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for (..)

Insulin 131

Insulin Production 131

Pharmaceutical Technology

NOVEMBER 1, 2022

FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. What are Product Launches? The Product Launches category recognises companies that have launched notable new products or services into the market.

Production 130

Production Marketing Manufacturing Vaccination 130

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 7, 2024

The Central Drugs Standard Control Organisation (CDSCO) has come out with a draft of revised guidance document for the industry related to the quality, safety and efficacy documents for Post Approval Changes (PACs) in biological products in order to align the standards with the international guidelines including that of World Health Organisation (WHO) (..)

Production 196

Production Drugs Clinical Trials Clinical Trials 196

pharmaphorum

APRIL 8, 2024

Creating a winning playbook for consistent digital product success involves strategic planning, execution, and continuous improvement. Discover key strategies and practices to ensure your digital products achieve lasting success.

Production 110

Production 110

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in rAAV production technology for the pharmaceutical industry.

Gene Therapy 223

Gene Therapy Production Gene 223

Pharmaceutical Technology

SEPTEMBER 14, 2023

Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.

Production 173

Production Drugs 173

World of DTC Marketing

APRIL 5, 2022

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

Production 196

Production Pharma Companies Branding Marketing 196

Bio Pharma Dive

FEBRUARY 19, 2021

The drugmaker will use production lines at its plant in McPherson, Kansas to help fill vaccine vials, company CEO Albert Bourla said Friday.

Production 357

Production Vaccination Vaccine 357

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”

Production 240

Production Vaccination Vaccine Life Science 240

XTalks

MAY 3, 2024

To combat food poisoning, US agriculture officials introduced a final rule last Friday, mandating significant reductions in Salmonella bacteria in specific chicken products. Starting in 2025, high levels of Salmonella in frozen breaded and stuffed chicken products will classify them as adulterated. How Common Is Salmonella in Chicken?

Regulation 101

Regulation Production Contamination Packaging 101

Fierce Pharma

APRIL 25, 2024

Where innovation meets obstacles and the cost of drug development skyrockets, the key to unlocking success of groundbreaking products in the biopharma industry will rely heavily on strategic | Collaborative partnerships key to clearing the path for new biopharma products

Production 94

Production Development Drugs 94

Pharma Mirror

FEBRUARY 6, 2024

In addition to utilizing RWE in clinical research, there is a growing trend toward implementing RWE early in the product development lifecycle. In recent years, European regulators have supported the The post RWE’s Impact on Product Lifecycle for Biopharma Startups appeared first on Pharma Mirror Magazine.

Production 100

Production Packaging Packaging Clinical Research 100

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 15, 2024

a global leader in analytical and clinical laboratory technologies, announced that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. Agilent Technologies Inc.,

Production 146

Production Development Scientist Drugs 146

Bio Pharma Dive

SEPTEMBER 18, 2023

As integrated evidence generation takes center stage for driving evidence-based decision making across the product life cycle, automated registries just might be the linchpin that pulls it all together.

Production 148

Production 148

Pharmaceutical Technology

JUNE 27, 2023

Tonix Pharmaceuticals and Tonix Medicines have signed an agreement for the acquisition of Upsher-Smith Laboratories’ two migraine products.

Production 130

Production Medicine 130

Pharma Mirror

JANUARY 24, 2023

At the core of this trend is replacing outdated legacy manufacturing techniques where cells The post Modernizing Therapeutic Cell Production appeared first on Pharma Mirror Magazine. With so much at stake, attention is now shifting to adopting more modern equipment and methods to consistently produce the best cells.

Production 130

Production Gene Therapy Manufacturing Gene 130

Pharmaceutical Technology

DECEMBER 5, 2022

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. TherapeuticsMD will also sell specific assets to Mayne, permitting the latter to market these products, including inventory. Additionally, TherapeuticsMD is entitled to receive another nearly $13.1m

Licensing 130

Licensing Licensing Production Marketing 130

Pharmaceutical Technology

DECEMBER 7, 2023

However, during this process, some drug product loss is inevitable. Sterile filling is a critical step in pharmaceutical primary packaging.

Production 130

Production Packaging Packaging Drugs 130

Pharmaceutical Technology

JULY 4, 2023

Tonix Pharmaceuticals and Tonix Medicines have acquired two migraine products from Upsher-Smith Laboratories.

Production 130

Production Medicine 130

Pharmaceutical Technology

AUGUST 9, 2023

GenScript Biotech has expanded the peptide production capabilities at its new life-sciences manufacturing facility located in Zhenjiang.

Production 130

Production Life Science Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 28, 2023

Pharmaceutical Technology has listed some of the leading providers of product inspection, testing and detection equipment and services in the pharmaceutical industry.

Production 130

Production 130

BioPharma Reporter

APRIL 17, 2024

BSI, sat down with Liza Laws, the senior editor of OSP and BPR to discuss his companyâs pioneering work in revolutionizing vaccine adjuvant production. During DCAT this year, Gaston Saperi from Botanical Solutions Inc.,

Production 95

Production Vaccination Vaccine Clinical Development 95

Pharmaceutical Technology

SEPTEMBER 29, 2023

Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance the product pipeline.

Production 130

Production 130

Pharmaceutical Technology

JULY 7, 2023

Cryo-milling allows users to reduce polymer-type products to powder and limit degradation, preserving the quality of the product.

Production 147

Production 147

Pharmaceutical Technology

MARCH 13, 2024

In T-cell manufacturing, the historical issue of maintaining the quality of materials when scaling up production is changing.

Production 130

Production Manufacturing 130

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 23, 2023

The Central drug regulator has issued alert on suspected falsified versions of Glucagon-like peptide 1 receptor agonist (GLP-1-RA) products, an anti-diabetes management drug, in the market. GLP-1-RA […]

Production 151

Production Marketing Regulation Drugs 151

Pharmaceutical Technology

DECEMBER 14, 2022

Harrow has signed a binding agreement to acquire exclusive US commercial rights to five ophthalmic products of Novartis. These products, namely, Ilevro, Vigamox, Maxidex, Nevanac and Triesence, have received approval from the Food and Drug Administration (FDA). Outside of the US region, Novartis will have sole rights to the products.

Production 147

Production FDA Approval Marketing Branding 147

Pharmaceutical Technology

FEBRUARY 28, 2023

Dr Reddy’s Laboratories has signed a definitive agreement to buy Australian company Mayne Pharma Group’s US generic prescription product portfolio in a deal valued at approximately $105m. Mayne Pharma’s portfolio to be acquired comprises around 45 commercial products, four pipeline products and 40 approved, non-marketed products.

Production 130

Production Hormones Marketing Medicine 130

Drug Discovery World

MAY 7, 2024

Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.

Antibody 59

Antibody Production Manufacturing Engineer 59

Fierce Pharma

MAY 3, 2024

Much of the boost can be attributed to sales of products acquired in Amgen’s $27.8 . | The buzz about Amgen’s obesity prospects overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase. billion buyout of Horizon Therapeutics, which was completed early in the fourth quarter of last year.

Production 93

Production Sales 93